Please login to the form below

Not currently logged in
Email:
Password:

GSK’s Tim Brooks joins Creative Leap

Brooks will take responsibility for strategy development, while also supporting specific client relationships and projects.  

Tim Brooks, Creative Leap 

Former GlaxoSmithKline (GSK) healthcare marketing director Tim Brooks has joined London-based communications agency Creative Leap as a non-executive director.

The appointment will be a 'hands on' role, with Brooks taking responsibility for strategy development, while also supporting specific client relationships and projects.

Over the course of 11 years with GSK, he managed a marketing department of more than 30 people that covered brand marketing, innovation, research and expert marketing across a portfolio of brands.

“We have known Tim for a long time and we feel that his commercial input and extensive marketing and healthcare experience will help to take the business forward particularly within our health and wellbeing practice areas,” said David Gray, CEO, Creative Leap.

“This is one of a number of steps we are undertaking to enhance our ability to add value to our clients.”

Creative Leap's involvement in the healthcare sector has included working with GSK, Alliance Boots, Bupa, Johnson & Johnson, Merz Aesthetics and also with Reckitt Benckiser.

Commenting on his appointment, Brooks said: “I have known Creative Leap since its birth – they do some fabulous work – and I look forward to contributing to their future success.

“Clients face huge challenges as they seek sustainable growth and differentiation and we all share a view about how to put this – rather than typical agency rhetoric - at the heart of our approach.”

2nd July 2012

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CACTUS

Founded in 2002, Cactus Communications is a fully integrated, global scholarly communications company with offices in Japan, South Korea, India,...

Latest intelligence

ema1
The European Medicines Agency: PRIME’d for access?
Leela Barham examines the impact of the EMA's PRIME fast track system after two years...
How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...

Infographics